Gain Therapeutics GANX
NASDAQ GANX
$1.11 +0.03 (+2.78%)
At close: Nov 11, 2026 · 4:00 PM EST

Gain Therapeutics (GANX) Long-Term Debt Issuances (2020 - 2026)

Updated

Gain Therapeutics' Long-Term Debt Issuances came in at $30,396 for Q4 2020, down 92.8% from the prior quarter.

Analysis

Gain Therapeutics (GANX) Long-Term Debt Issuances (2020 - 2026) Analysis & Trends

For FY2020, Gain Therapeutics' Long-Term Debt Issuances was $738,282.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 9.98 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Gain Therapeutics 47.87 Mn -14.31 Mn - 1.78 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 1.78 Mn
Jun 30, 2026 1.39 Mn
Mar 31, 2026 427,783.00
Jun 30, 2025 2.49 Mn
Mar 31, 2025 2.42 Mn
Dec 31, 2024 2.34 Mn
Dec 31, 2020 30,396.00
Sep 30, 2020 423,288.00
Mar 31, 2020 284,598.00
API Access

Gain Therapeutics Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=GANX&period=max&api_key=YOUR_API_KEY